We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
There were no significant changes in renal function or serumpotassium.
2
Nine of the 10 patients had a persistent decrease in predialysis serumpotassium concentration.
3
Transient but significant drops in serumpotassium and phosphorus were also observed during hyperthermia.
4
Safety end points were changes from baseline in serumpotassium and estimated glomerular filtration rate.
5
Exercise caused a marked increase in serumpotassium concentrations.
6
On GA, mean predialysis serumpotassium was significantly lower than at baseline or on placebo.
7
Two risk factors were identified: advanced gestational age and serumpotassium at the upper limit of normal.
8
Most of the strategies to control serumpotassium level in the short term have been used for decades.
9
The patient responded to standard therapy for hyperkalemia on both occasions and serumpotassium levels returned to normal.
10
After surgery serumpotassium concentration returned to normal in all patients showing low serumpotassium levels before surgery.
11
Conclusions: Add-on spironolactone is a highly effective add-on treatment in UH, mainly in patients with low serumpotassium levels.
12
We sought to determine the association between serumpotassium concentration and cardiovascular disease risk in the Framingham Heart Study.
13
The patient was discharged from the hospital without further complications and post-operative rechecks showed persistently normal serumpotassium levels.
14
We studied the pattern of serumpotassium levels in a cohort of Chinese peritoneal dialysis (PD) patients.
15
These were associated with a significant decrease in heart rate and an increase in serumpotassium level and glucose concentration.
16
Methods: We studied serumpotassium levels of 266 PD patients during 3 consecutive clinic visits.